Background/Aims: Estrogen could play a key role in the mechanisms underlying sex-related disparity in the incidence of thrombotic events. We investigated whether estrogen receptors (ERs) were expressed in human red blood cells (RBCs), and if they affected cell signaling of erythrocyte constitutive isoform of endothelial NO-synthase (eNOS) and nitric oxide (NO) release. Methods: RBCs from 29 non-smoker volunteers (15 males and 14 females) aged between 20 and 40 years were analyzed by cytometry and western blot. In particular, content and distribution of ER-α and ER-β, tyrosine kinases and eNOS phosphorylation and NO release were analyzed. Results: We demonstrated that: i) both ER-α and ER-β were expressed by RBCs; ii) they were both functionally active; and iii) ERs distribution and function were different in males and females. In particular, ERs modulated eNOS phosphorylation and NO release in RBCs from both sexes, but they induced the phosphorylation of specific tyrosine residues of kinases linked to eNOS activation and NO release in the RBCs from females only. Conclusion: Collectively, these data suggest that ERs could play a critical role in RBC intracellular signaling. The possible implication of this signaling in sex-linked risk disparity in human cardiovascular diseases, e.g. in thrombotic events, may not be ruled out.
Functional Estrogen Receptors of Red

Introduction
Red blood cells (RBCs) have been proposed as real-time biomarkers and pathogenetic determinants in several human cardiovascular diseases (CVD) [1, 2] . Changes in RBC morphological and functional characteristics such as adhesivity, aggregability, and
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Western Chemiluminescent HRP Substrate (Millipore, Mussachusset, USA). Densitometric scanning analysis was performed by ChemiDoc MP system (Bio-Rad). To ensure the presence of equal amounts of protein, the membranes were reprobed with an anti-GAPDH (Santa Cruz).
Statistical analyses
Cytofluorimetric results were statistically analyzed by using the nonparametric Kolmogorov-Smirnov test using Cell Quest Software. At least 20, 000 events were acquired. The median values of fluorescence intensity histograms were used to provide a semiquantitative analysis. Student's t-test was used for the statistical analysis of the collected data.
Results
ERs content and localization in RBCs from males and females
ER content and localization were evaluated in RBCs from blood samples of healthy age-matched pre-menopausal females and males, by using different techniques. By flow cytometry analysis, we found that both ER-α and ER-β were expressed in RBCs, but differently in males and females (Fig. 1A, left panel) . In particular, ER-α content was significantly (p < 0.001) higher in RBCs from males, while ER-β content in RBCs was comparable between the two sexes. Typical flow cytometric profiles of ER-α and ER-β content in RBCs from a representative male and a representative female were shown in Fig. 1A (right panels). The analysis of ER-α content by western blotting confirmed that ER-α was significantly higher in RBCs from males than from females (p < 0.05, Fig. 1B , left panels) whereas no significant differences were observed regarding ER-β content in RBCs from both sexes (Fig. 1B, right  panels) . We further investigated ER-α and ER-β distribution in RBCs by immunofluorescence analysis. The representative images of Fig. 1C show that ER-α (left panel) and ER-β (right panel) were differently distributed in RBCs from males and females. In RBCs from the males, ER-α was mainly localized in the cytoplasm, while in the female RBCs it was mainly localized in the subcortical region. By contrast, no sex difference was detectable in ER-β distribution with a predominance in cytoplasm localization (Fig. 1C, right panels) . The different localization of ER-α and ER-β in RBCs in male and female was then evaluated by western blotting analysis on purified RBC membranes. The obtained results confirmed that: i) ER-α membrane content was significantly higher in RBCs from females than in those from males (left panels) and ii) ER-β (right panels) expression in cell membrane was similar in RBCs from both sexes (Fig. 1D) . Hence, to evaluate whether ERs could be recruited to the membrane after activation by 17β estradiol (E2), RBCs of 8 pre-menopausal females, 8 postmenopausal females and 8 males were treated for 5 min with 10 and 30 nM E2 (Fig. 2) . E2 treatment significantly increased ER-α ( Fig. 2A and B) and ER-β ( Fig. 2C and D) recruitment at plasma membrane in RBCs from pre-menopausal females, post-menopausal females, and males. These data supported a role for estrogen in the recruitment of ER-α, at membrane level in RBCs, potentially explaining its higher membrane content in RBCs from pre-menopausal females in comparison to those from males.
ERK1/2, AKT/PI3K, P38 content and phosphorylation signaling pathway in RBCs from males and females
As reported by Nakaya and co-workers [13] , in ECs, ERs-mediated signaling was linked to the phosphorylation of some key kinases, such as ERK1/2, AKT/PI3K and P38. To investigate the likely existence of a similar pathway in RBCs, and to evaluate potential sex differences in these signaling, we compared the content and the phosphorylation levels of these kinases in RBCs from healthy age-matched pre-menopausal females and males by flow cytometry and western blotting analysis (Fig. 3) . We found that ERK1/2 ( Fig. 3A and B) and AKT ( Fig.  3C and D) were contained in RBCs in a sex-independent manner. Conversely, P38 content was significantly higher in RBCs from males than in those from females (p < 0.05) by flow cytometry (Fig. 3E ) and western blotting (Fig. 3F) . Moreover, we found that in RBCs of both sexes, ERK1/2, AKT, and P38 were present in their phosphorylated states and that the levels of p-ERK1/2 ( Fig. 3A and B, right panels), p-AKT ( Fig. 3C and D, right panels), and p-P38 ( Fig.  3E and F, right panels) were significantly higher in RBCs from females than in those from males (p < 0.05 for p-ERK1/2 and p <0.01 for p-AKT and p-P38). 
ER-α and ER-β activation and ERK1/2, AKT/PI3K and P38 phosphorylation in RBCs from males and females
To evaluate ER function in kinase phosphorylation, we stimulated the receptors with the ER-α agonist PPT or with the ER-β agonist DPN. Western blotting analysis showed that PPT and DPN treatments affected the content of the phosphorylated kinase fractions in a sex-dependent manner (Fig. 4) . In particular, a decreased content of p-ERK1/2, p-AKT and p-P38 was measured in males (Fig. 4A-C, left panels) . Conversely, an increased content of these phosphorylated proteins was measured in treated RBCs from females ( Fig. 4A-C,  middle panels) . Again, these data were confirmed by cytofluorimetric analysis (Fig. 4A-C,  right panels) . In fact, a decreased content of p-ERK1/2 (-16% and -35% for PPT and DPN, respectively), p-AKT (-27% and -39% for PPT and DPN, respectively) and p-P38 (-7 % and -26%, respectively) was measured in males, whereas an increase in p-ERK1/2 (+16% and +28% for PPT and DPN, respectively), p-AKT (+69% and +65% for PPT and DPN, respectively) and p-P38 (+13 % and +20%, respectively) was detected in females. To confirm that both ER-α and ER-β activation could be involved in these events, we treated RBCs with E2 in presence of MPP and THC, selective antagonists of ER-α and ER-β respectively. In RBCs from females both the ER antagonists significantly reduced AKT/PI3K phosphorylation induced by E2, whereas in RBCs from males no significant effect was observed ( Supplementary Fig.  1 -for all supplemental material see www.cellphysiolbiochem.com). These results highlight the sex-dependent activation of ER, which can affect the kinase-mediated intracellular signaling in RBCs from females.
RBC eNOS phosphorylation and NO production
The evidence of sex differences in ER-mediated phosphorylation of kinases, process known to be involved in eNOS activation, led us to hypothesize that eNOS activity could be subject to sex-related control in RBCs. To address the issue, we looked for the presence of a functionally active eNOS in RBCs. Considering that eNOS phosphorylation at Ser-1177 residue is the pre-requisite for the activation of the enzyme and NO production [26] [27] , we measured the amount of phosphorylated eNOS (p-eNOS) by both flow cytometry (Fig. 5A , left panels) and western blotting analysis (Fig. 5A, right panels) . Data showed that p-eNOS content was significantly (p < 0.05) higher in RBCs from females than in RBCs from males (Fig. 5A) . To further dissect the connection between ERs-linked signaling and NO pathway, we measured p-eNOS content in RBCs treated with ER agonists (Fig. 5B) . Western blotting analysis showed that treatment with PPT and DPN increased significantly p-eNOS levels in RBCs from both males and females (Fig. 5B, left and middle panels, respectively) . Flow cytometry analysis confirmed that the treatment of RBCs with PPT and DPN increased the phosphorylated form of p-eNOS by 24% and 38% in RBCs from males, and by 46% and 21% in RBCs from females, respectively (Fig. 5B, right panel) . Since p-eNOS is a prerequisite for NO production, constitutive levels of NO were measured by flow cytometry (Fig. 5C, left and middle panels). Interestingly, a significant (p < 0.05) sex difference in NO content was found as RBCs from females released more NO than those from males. Using ER agonists, we found that in RBCs from males NO release increased by about 15% and 16% after PPT and DPN treatment, respectively. In RBCs from females, NO release increased by about 20% after PPT treatment and, surprisingly, decreased by about 16% after DPN treatment (Fig. 5C, right  panel) . These data highlight that eNOS phosphorylation and NO production are under the control of ERs in RBCs from both males and females. 
Discussion
In this study, we observed that: i) both ER-α and ER-β were expressed by RBCs; ii) they were both functionally active; and iii) ERs distribution and function were different in healthy age-matched pre-menopausal females and males. In RBCs from pre-menopausal females, ER-α was mainly localized at the plasma membrane, whereas in RBCs from the males, it was mainly localized in the cytoplasm. Interestingly, estrogen was able to recruit ER-α and ER-β at membrane level not only in pre-menopausal, but also in post-menopausal females and in males. To note that ER-α and ER-β localized at the plasma membrane are well-known to have the ability of initiating membrane delimited signaling, which enhances kinase signaling pathways. In this study we observed a higher level of the active, phosphorylated kinases in RBCs from female than in those from males. When ER-α or ER-β were activated by PPT (ER-α agonist) or DPN (ER-β agonist), phosphorylated kinase level increased further only in RBCs from females supporting a role for ER in this process and partially explaining the basal higher levels of phosphorylated kinases in pre-menopausal females, naturally exposed to estrogen.
Membrane-associated ER-α and/or ER-β have been demonstrated to mediate eNOS phosphorylation via activation of the PI-3 kinase/AKT pathway [28] [29] [30] , but sex differences in this process has not been investigated yet. In this study, the content of phosphorylated eNOS and NO appeared more elevated in female RBCs in comparison with male RBCs. We observed that the stimulation of ERs induced eNOS phosphorylation and NO production in both males and females. Again, this results suggest that the natural exposure of RBCs to estrogen in pre-menopausal females could induce a higher basal levels of phosphorylated eNOS and NO in comparison to males. Moreover, our data suggest that in RBCs from females, the ER-mediated induction of eNOS phosphorylation and NO production could be triggered by kinase phosphorylation, whereas in RBCs from males other pathways may be involved. In fact, estrogen has been shown modulate NO production by a variety of alternative mechanisms [31] [32] [33] [34] [35] . Interestingly, confirming our results, estrogen supplementation has been observed to improve eNOS dependent vascular function in male transsexuals suggesting that effects of this steroid are present in both males and females [36] [37] . Additionally, other sex associated factors, such as progesterone, could have a role in sex-related differences in RBC physiology modulating eNOS phosphorylation and NO production [38] [39] and further studies are ongoing in our laboratories to better clarify the role of progesterone /progesterone receptors in RBC physiopathology.
Conclusion
Our study provides new lines of evidence supporting that ERs play a role in the modulation of RBCs intracellular signaling in males and females.
Estrogen regulation of eNOS in RBCs and bioavailability of NO may contribute to variability in risk factors, presentation of, and treatment for cardiovascular disease associated with aging, pregnancy, stress, and metabolic disorders in males and females [40] . Interestingly, Grau et al. [23] showed that RBC deformability were gender dependent and related to different estradiol levels that affect NO synthesizing pathways. A better understanding of the effects of ER-α and ER-β in this context could open new paths in therapeutic strategies based on the use of ER selective agonists such as phytoestrogens, e.g., genistein or silibinin.
